Skip to main content
. Author manuscript; available in PMC: 2021 Jul 30.
Published in final edited form as: Bioorg Chem. 2020 Mar 20;99:103778. doi: 10.1016/j.bioorg.2020.103778

Figure 2.

Figure 2

Visualization of the docking results: Protein - ligand interaction of crizotinib and prodrug A in complex with c-MET (A) and ALK (B). In both structures, the main hydrogen bonds of the 2-aminopyridine moiety of crizotinib that are essential for the tyrosine kinase inhibition are suppressed. In case of c-MET, additionally the crucial π-π interaction between the 2,6-dichloro-3-fluorophenyl moiety and Tyr-1230 is disturbed.